Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Gubra (Denmark)
h-index: 50
Total citations: 9,043
Total papers: 279
Homepage:
https://www.gubra.dk/
Recent papers from Gubra (Denmark)
Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis
Nature Metabolism · 2020
Nephroprotective Effects of the Dual GCGR / GLP ‐ 1R Agonist Survodutide in Hypertension‐Accelerated Diabetic Kidney Disease
Diabetes Obesity and Metabolism · 2026
Light-Mediated Desulfurization of Peptides in Multi-Well Format for Combinatorial Library Synthesis
Molecules · 2026
Adaptive oligodendrogenesis regulates blood-hypothalamus barrier permeability, hypothalamic glucose sensing and systemic glucose homeostasis in male mice
Molecular Metabolism · 2026
Semaglutide attenuates neuroinflammation in male mice
Nature Communications · 2026
A74-19 Molecular Hallmarks of Lung Cellular Senescence in Single vs. Repetitive Bleomycin-induced and Spirometry-confirmed Mouse Models of IPF
American Journal of Respiratory and Critical Care Medicine · 2026
Therapeutic Efficacy, Biomarker Signatures and Translatability of Semaglutide in the Liver Biopsy-Confirmed GAN DIO-MASH Mouse Model
AJP Gastrointestinal and Liver Physiology · 2026
Nintedanib Lacks Efficacy in a Spirometry‐Confirmed and Bleomycin‐Induced Mouse Model of Idiopathic Pulmonary Fibrosis
Basic & Clinical Pharmacology & Toxicology · 2026
Survodutide acts through circumventricular organs in the brain and activates neuronal regions associated with appetite regulation
Molecular Metabolism · 2026
HMB-002: A Monovalent Antibody that Elevates Circulating VWF and FVIII Levels for Treatment of Von Willebrand Disease
Blood Advances · 2026
Generation and characterisation of a humanised GLP-1 receptor mouse model for translational drug development
EBioMedicine · 2026
Metformin Protects Against Persistent Atrial Fibrillation in an Equine Model
Circulation Arrhythmia and Electrophysiology · 2025
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long‐Acting FGF21 Analog Zalfermin
Clinical and Translational Science · 2025
Transferrin receptor-binding blood-brain barrier shuttle enhances brain delivery and plaque-clearing efficacy of a therapeutic anti-Aβ antibody
Fluids and Barriers of the CNS · 2025
Temporal glomerular gene expression dynamics during disease progression in a mouse model of hypertension‐accelerated diabetic kidney disease
Animal Models and Experimental Medicine · 2025
The combination of zalfermin and semaglutide has additive therapeutic effects in a diet-induced obese and biopsy-confirmed mouse model of MASH
PLoS ONE · 2025
Deep learning‐enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis
British Journal of Pharmacology · 2025
Distinct lung functional, histological and cell senescence signatures in the single and repetitive bleomycin mouse models of idiopathic pulmonary fibrosis.
2025
Mucosal transcriptomic landscape along the small and large intestines in individuals with and without type 2 diabetes
Gut · 2025
Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide
Molecular Metabolism · 2025